- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tot Biopharm International Co Ltd (1875)
Tot Biopharm International Co Ltd stock price live, this page displays HK 1875 stock exchange data. View the 1875 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tot Biopharm International Co Ltd real time stock price chart below.
What Is the Tot Biopharm International Co Ltd Stock Price Today?
The Tot Biopharm International Co Ltd stock price today is 1.95.
What Is the Stock Symbol for Tot Biopharm International Co Ltd?
The stock symbol for Tot Biopharm International Co Ltd is "1875."
What Stock Exchange Does Tot Biopharm International Co Ltd Trade On?
Tot Biopharm International Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Tot Biopharm International Co Ltd a Good Stock to Buy?
Determining whether Tot Biopharm International Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1875 quote. (ISIN: HK0000545266)
What Is the Tot Biopharm International Co Ltd Stock Price Today?
The Tot Biopharm International Co Ltd stock price today is 1.95.
What Is the Stock Symbol for Tot Biopharm International Co Ltd?
The stock symbol for Tot Biopharm International Co Ltd is "1875."
What Stock Exchange Does Tot Biopharm International Co Ltd Trade On?
Tot Biopharm International Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Tot Biopharm International Co Ltd a Good Stock to Buy?
Determining whether Tot Biopharm International Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1875 quote. (ISIN: HK0000545266)
Hong Kong
Currency in HKD
1.95
-0.06(-2.99%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.94
2.01
52 wk Range
1.48
2.79
1875 Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.942.01
52 wk Range
1.482.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1875 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Analysts Sentiment
Strong Buy
Price Target
2.36
Upside
+20.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
No news in this category
Looks like there are no results in this news category
Tot Biopharm Intl Company Profile
TOT BIOPHARM International Company Limited, an investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in China. The company develops and markets Pusintin, a bevacizumab injection for the treatment of non-squamous non-small cell lung cancer; metastatic colorectal cancer; recurrent glioblastoma multiforme; epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer; cervical cancer; and hepatocellular carcinoma. It also offers Tazian, a temozolomide capsule for the treatment of glioblastoma multiforme or anaplastic astrocytoma; and Megaxia, a megestrol acetate oral suspension for the treatment of anorexia associated with acquired immunode¬ciency syndrome, as well as signi¬cant weight loss of AIDS and cancer patients caused by cachexia. In addition, the company is developing TAB014 that has completed Phase III clinical trial for the treatment of wet age-related macular degeneration (wAMD). Further, it develops products under preclinical trials, including TAE020 for acute myeloid leukemia; and TAC020 for the treatment various solid tumors. Additionally, the company engages in contract development and manufacturing organization (CDMO)/contract manufacture organization (CMO) business; and license-out of self-developed biological drugs. TOT BIOPHARM International Company Limited was incorporated in 2009 and is headquartered in Suzhou, China.
Compare 1875 to Peers and Sector
Metrics to compare | 1875 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1875PeersSector | |
|---|---|---|---|---|
P/E Ratio | 41.1x | −9.1x | −0.5x | |
PEG Ratio | 0.21 | −0.09 | 0.00 | |
Price/Book | 2.0x | 3.7x | 2.6x | |
Price / LTM Sales | 1.3x | 10.9x | 3.0x | |
Upside (Analyst Target) | 20.7% | 16.6% | 57.1% | |
Fair Value Upside | Unlock | 9.1% | 10.6% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 2.36
(+20.83% Upside)
FAQ
What Is the Tot Biopharm Intl (1875) Stock Price Today?
The Tot Biopharm Intl stock price today is 1.95.
What Stock Exchange Does Tot Biopharm Intl Trade On?
Tot Biopharm Intl is listed and trades on the Hong Kong stock exchange.
What Is the Stock Symbol for Tot Biopharm Intl?
The stock symbol for Tot Biopharm Intl is "1875."
What Is the Tot Biopharm Intl Market Cap?
As of today, Tot Biopharm Intl market cap is 1.55B.
What is Tot Biopharm Intl Earnings Per Share?
The Tot Biopharm Intl EPS is 0.048.
From a Technical Analysis Perspective, Is 1875 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.